GlassScriptPhysician profile
Jerrod Anderson
NPI 1013302587
$1,266.16
in general payments reported to CMS, 2019-2025
19 companies · $572 in 2025
The $572 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $22.23 · 2022: $57.80 · 2023: $112 · 2024: $303 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878 · Gift: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.15 |
| Gift | $108.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $221.56 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $187.94 | 2019-2023 | |
| Abiomed | $108.65 | 2024 | Impella |
| Abbvie INC. | $100.98 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.39 | 2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $89.94 | 2024-2025 | Airsupra, Farxiga |
| Exact Sciences Corporation | $85.36 | 2024-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $54.96 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Shockwave Medical, INC | $52.27 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lilly USA, LLC | $44.05 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $40.02 | 2024-2025 | Krystexxa |
| Otsuka America Pharmaceutical, INC. | $38.58 | 2023-2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $27.07 | 2024-2025 | Voquezna |
| Alkermes, INC. | $22.85 | 2023 | Vivitrol |
| Gilead Sciences, INC. | $19.38 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $19.30 | 2024 | (6536) Phoenix |
| Daiichi Sankyo INC. | $19.13 | 2024 | Injectafer |
| Janssen Pharmaceuticals, INC | $17.56 | 2019 | |
| Eisai INC. | $16.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerrod Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.